Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort. [electronic resource]
Producer: 20181029Description: 594-605 p. digitalISSN:- 1423-0143
- 2-Naphthylamine
- Anilides -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Antiviral Agents -- adverse effects
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Kidney Failure, Chronic -- therapy
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Renal Insufficiency -- therapy
- Ritonavir -- therapeutic use
- Sulfonamides -- therapeutic use
- Treatment Outcome
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.